BiotechTube

Azelaic Acid foam 15%

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Rosacea, Papulopustular

Conditions

Rosacea, Papulopustular

Trial Timeline

Dec 6, 2017 → Jan 9, 2019

NCT ID
NCT03418610

About Azelaic Acid foam 15%

Azelaic Acid foam 15% is a approved stage product being developed by Bayer for Rosacea, Papulopustular. The current trial status is completed. This product is registered under clinical trial identifier NCT03418610. Target conditions include Rosacea, Papulopustular.

What happened to similar drugs?

4 of 14 similar drugs in Rosacea, Papulopustular were approved

Approved (4) Terminated (2) Active (8)
✅Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
✅Azelaic acid 15% + Brimonidine 0.33%BayerApproved
✅azelaic acid 15% gel + azelaic acid 15% gelBayerApproved
✅Oxymetazoline HCL 1.0% CreamAclaris TherapeuticsApproved
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
🔄Azelaic acid foam, 15% (BAY39-6251) + Vehicle foamBayerPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT03418610ApprovedCompleted
NCT01025635Phase 2Completed

Competing Products

20 competing products in Rosacea, Papulopustular

See all competitors
ProductCompanyStageHype Score
DFD-04 OintmentDr. Reddy's LaboratoriesPhase 2
32
Minocycline hydrochloride capsulesDr. Reddy's LaboratoriesPhase 1
26
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
DFD-29 Extended Release Capsules (40 mg) + DFD-29 Extended Release Capsules (20 mg) + Oraycea® (doxycycline) Capsules + Placebo CapsulesDr. Reddy's LaboratoriesPhase 2
32
DoxycyclineDr. Reddy's LaboratoriesPhase 1
26
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
Lotilaner Gel, 2.0%Tarsus PharmaceuticalsPhase 2
29
lotilaner + VehicleTarsus PharmaceuticalsPhase 2
36
DRM02Eli LillyPhase 2
35
Clascoterone Cream 1%Sun PharmaceuticalPhase 2
42
Metronidazole Topical Gel 1% + Metronidazole Topical Gel 1% (Metrogel) + PlaceboSun PharmaceuticalPhase 1
29
Azelaic Acid 15% topical gel + Finacea® (azelaic acid) Gel, 15% + PlaceboSun PharmaceuticalPhase 1
29
Azelaic acid foam 15% + Finacea® (Azelaic acid Foam) 15% + Vehicle of the test productSun PharmaceuticalPhase 1
29
Laropiprant + Placebo for LaropiprantMerckPhase 1
29
AMG 334NovartisPhase 2
31
BFH772 1% ointment + Vehicle ointment + Noritate® 1% creamNovartisPhase 2
35
Deucravacitinib + PlaceboBristol Myers SquibbPhase 2
27
Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
40
Coppertone, BAY1183345BayerPre-clinical
23
Azelaic acid 15% + Brimonidine 0.33%BayerApproved
40